AXAxinet
Menu
Finance

Live market screen

Commercial Space Company Risk / Opportunity Ranking

Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.

Updated June 27, 2026

Companies analyzed
438
Ranked rows
876
Evidence links
356
Rows per page
20

Opportunity view

Showing rows 81-100 of 438; 20 rows per page.

Sorted by raw opportunity score
RankCompanyScoreThesis / Evidence
81
Atomic-6
lowweak
Opp 4
Risk 5

Thesis: Atomic-6 appears to have meaningful strategic upside because the membership rationale says it launched an orbital data center service and has DoD and U.S. Space Force contracts, which would support a long-duration defense/space infrastructure thesis if confirmed.

Why now: The reviewed sources rationale cites article and says Atomic-6 launched an orbital data center service and has DoD and U.S. Space Force contracts, but no representative article or is provided in the visible reviewed sources, so timing confidence is limited.

Caveats: No direct evidence or article are available in the reviewed sources body. Opportunity thesis relies on membership rationale rather than citable article summary. Because the underlying evidence is not exposed, conviction must stay low.

82
Beijing Guodian High-Tech Technology Co
lowweak
Opp 4
Risk 2

Thesis: Reviewed evidence rationale says the company received approval for a commercial satellite IoT pilot program using the Tianqi constellation of 41 satellites. Regulatory or pilot approval tied to an existing constellation is a meaningful long-horizon opportunity signal if execution follows.

Why now: The implied catalyst is the pilot-program approval, but the reviewed sources provide no retained article summary or timestamped evidence row beyond the membership rationale.

Caveats: Phase2 membership rationale references: but the actual summary/evidence are absent. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Opportunity score is restrained because approval alone is described in rationale but not directly evidenced here.

83
D-Orbit
lowweak
Opp 4
Risk 3

Thesis: Moderate evidence-ranked opportunity: the reviewed sources membership rationale says D-Orbit partnered with Magdrive for an electric propulsion demo and places the company in satellite propulsion/orbital logistics, which suggests active technology development aligned with durable LEO and sustainability themes over a 1 year+ horizon.

Why now: Why now is the partnership/demo claim referenced in article ID, but the reviewed sources includes neither nor explicit article timing beyond the article ID prefix, limiting recency precision.

Caveats: Opportunity rests on membership rationale rather than fully available direct evidence. Referenced article ID has no in the reviewed sources. Demo activity is not the same as proven commercial traction.

84
Dhruva Space
lowweak
Opp 4
Risk 2

Thesis: Among this screen, Dhruva Space has one of the stronger reviewed sources rationales: it is described as having received a government grant for Project Garud, a 500 kg-class satellite platform for constellation-scale missions, and later partnering with ICEYE on satellite systems and Earth observation services. If current, those items imply platform and partnership traction that could matter over a 1 year+ horizon.

Why now: The reviewed sources references: and: in the membership rationale, suggesting relatively recent strategic developments, but the coverage report still shows zero evidence after recent evidence window, so timing confidence is limited.

Caveats: Positive thesis relies on membership rationale, not available direct evidence. Partnership evidence cannot be expanded through relation propagation beyond what is explicitly stated.

85
EDGX
lowweak
Opp 4
Risk 3

Thesis: Reviewed evidence rationale indicates EDGX is a Belgian spacetech startup with a prior €2.3M seed round and an in-orbit demonstration of its STERNA AI computing system on SpaceX Transporter-16. If still current, in-orbit validation plus prior funding can support a longer-horizon commercialization opportunity.

Why now: The membership support references articles, and, implying a narrative of funding plus orbital demonstration, but active evidence remains empty after recent evidence filtering, limiting recency confidence.

Caveats: In-orbit demo claim appears only in reviewed sources rationale, not available direct evidence. No evidence confirms whether the prior seed round falls within the current decision horizon relevance. No direct adverse evidence is present, but that is not proof of low fundamental risk.

86
Ellipsis Drive
lowweak
Opp 4
Risk 3

Thesis: Moderate opportunity on sparse evidence: the reviewed sources membership rationale describes Ellipsis Drive as addressing an Earth observation satellite-data processing bottleneck, with support from space agencies and target users including Earth observation firms. If accurate, that points to a software-layer position that could benefit over a 1 year+ adoption cycle.

Why now: Why now is the reviewed sources' claim that the company addresses a key EO data-processing bottleneck and has space-agency support, referenced to article ID: though no or timestamp detail was provided.

Caveats: Claims come from membership rationale rather than direct evidence. Referenced article ID: lacks a reviewed sources. Support from agencies and target users is weaker than demonstrated contracted revenue.

87
Eta Space
lowweak
Opp 4
Risk 2

Thesis: Eta Space has reviewed sources support that its LOXSAT mission will demonstrate 11 cryogenic fluid management technologies in space and that the mission is launched by Rocket Lab for NASA, indicating real technology validation relevance for in-space fueling or orbital servicing over a 1 year+ horizon.

Why now: The membership rationale specifically points to the LOXSAT mission demonstration as the current relevance driver, citing article: but the reviewed sources does not include the article or more detailed dated evidence fields.

Caveats: Underlying article is not provided in the reviewed sources. Score is based on membership rationale summary rather than available direct evidence. Single-mission validation is weaker than broad commercial traction.

88
Firefly Aerospace
lowweak
Opp 4
Risk 2

Thesis: Firefly has a positive long-horizon lunar infrastructure angle because recent article context says NASA awarded it a Moon Base contract for MoonFall, a 2028 mission to transport four drones for Artemis-site surveying.

Why now: A dated May 26, 2026 article puts a fresh NASA program win into the current evidence window, which can matter over a 1 year+ horizon even if revenue realization is later.

Evidence
  • Published May 26, 2026: NASA awarded Firefly Aerospace a contract to build the spacecraft for MoonFall, a mission scheduled for 2028 to transport four drones to survey Artemis landing sites. uk.investing.com

Caveats: Only one within the recent evidence window article is available. Evidence is supporting article context rather than stronger extracted direct events. Timing of mission realization is long-dated relative to the evidence window.

89
Hispasat
lowweak
Opp 4
Risk 2

Thesis: The reviewed sources membership rationale states Hispasat is part of the IRIS2 project and will manage the LEO shell. If current, that implies meaningful strategic positioning in a long-duration European satcom infrastructure program.

Why now: The only timing clue is the membership rationale referencing article, but the underlying article summary and are not included in these reviewed sources. Recency beyond the batch month label is uncertain.

Caveats: No representative article or is available in the reviewed sources despite the favorable rationale. Program-role evidence can be important, but without economics or milestones the opportunity case is incomplete.

90
Impulse Space
lowweak
Opp 4
Risk 4

Thesis: Membership rationale ties Impulse Space to a Pentagon deal for space-based interceptor prototypes and identifies orbital transfer vehicle relevance, which would be strategically meaningful over a 1 year+ horizon if confirmed with current evidence, but the reviewed sources does not load the underlying evidence or article summaries after recent evidence window, unavailable in reviewed sources).

Why now: Why now is only medium because defense-space prototype work can matter over a 1 year+ horizon, but the reviewed sources' available evidence is empty after recent evidence window, preventing higher-conviction ranking.

Caveats: No current evidence is provided for. No direct evidence remained after the recent evidence filter. Potential opportunity rests on membership rationale rather than available corroborated evidence.

91
MDA Space Ltd.
lowweak
Opp 4
Risk 3

Thesis: MDA Space shows some opportunity context from being identified as operating in in-orbit servicing and from an article saying it won a Radarsat replenishment satellite contract, which could support durable government-space demand if current.

Why now: Why-now is weak because both available representative articles are undated, so current timing and whether these items remain incremental versus already absorbed is uncertain

Evidence
  • Representative summary says MDA Space will build a radar imaging satellite for the Canadian Space Agency. spacenews.com
  • Representative summary lists MDA Space as an operating in-orbit servicing and assembly company. spaceindex.io

Caveats: Both cited articles are undated; recency is uncertain. Support is weak and based on article context, not direct positive events. No material adverse evidence is available, but no strong current catalyst is validated either.

92
Modul8
lowweak
Opp 4
Risk 3

Thesis: Reviewed evidence membership rationale says Modul8 is a spun-out space communications unit with $40m funding, lunar cellular network deployment, and Artemis spacesuit communications work. If still current, that is among the stronger long-horizon strategic opportunity setups in this screen, but the reviewed sources does not provide citeable direct evidence or article.

Why now: Among sparse names, the stated combination of funding plus lunar communications program exposure could matter over 1 year+, but recency cannot be validated from served evidence.

Caveats: The strongest claims are only in membership rationale and not backed by citeable -bearing evidence in the reviewed sources. No negative evidence does not equal low fundamental risk.

93
Momentus Inc
lowweak
Opp 4
Risk 5

Thesis: Membership rationale says Momentus secured a new commercial contract for its Vigoride-9 orbital service vehicle and identifies the company as an orbital service vehicle / orbital services platform business, which would support a real opportunity thesis for space logistics if current and corroborated. However, these reviewed sources have no direct evidence or article summaries after recent evidence window, so the opportunity score must stay modest (: and: unavailable in reviewed sources).

Why now: Why now is medium because an orbital services contract can matter over a 1 year+ horizon, but the reviewed sources' post-recent evidence window evidentiary absence prevents stronger timing confidence.

Caveats: No direct evidence remained after the recent evidence filter.

94
NEC Corporation
lowweak
Opp 4
Risk 2

Thesis: Membership rationale states NEC launched an Orbital Transfer Vehicle development project selected by JAXA and aims for Asia's first OTV deployment. That would be a credible long-horizon strategic opportunity if current, but the reviewed sources provide no available direct evidence or article summaries inside the recent evidence window to validate progress (: unavailable in reviewed sources).

Why now: Why now is medium rather than weak because an OTV development project can be durable over 1 year+, but evidentiary support in the reviewed sources are thin after recent evidence window.

Caveats: No current evidence is provided for No direct evidence remained after the recent evidence filter. Current milestone timing is unverified in the reviewed sources.

95
NewOrbit Space
mediummedium
Opp 4
Risk 4

Thesis: NewOrbit Space has a plausible long-horizon opportunity because an article says it is developing satellites for very low Earth orbit and raised $18.5 million in a Series A round, suggesting both a differentiated technical focus and capital to pursue it.

Why now: Why now is weaker than Aavuus because the article has no publication date. The reviewed sources explicitly says no is available and recency-sensitive claims should be treated cautiously., undated

Evidence
  • NewOrbit Space, a UK startup developing satellites for very low Earth orbit, has raised $18.5 million in a Series A investment round. spacenews.com

Caveats: Evidence is supporting article context only, not direct structured positive event evidence. Publication date is unavailable; recency is uncertain. Single-article support only; no independent confirmation.

96
NorthStar Earth & Space
lowweak
Opp 4
Risk 3

Thesis: NorthStar Earth & Space appears strategically relevant to space domain awareness and may have public-market access or financing optionality via a SPAC path, but these reviewed sources provide only limited supporting article context and no strong in-window direct facts for business traction.

Why now: The only dated evidence in this row is an April 27, 2026 article-level summary stating NorthStar Earth & Space plans to go public in a SPAC deal at a $300 million valuation. That may matter over a 1 year+ horizon, but the reviewed sources does not provide stronger company-specific direct evidence here.

Evidence
  • Published April 27, 2026: article summary says NorthStar Earth & Space plans to go public through a SPAC deal at a $300 million valuation and describes it as a Canadian space domain awareness company. satellitetoday.com

Caveats: Coverage is extremely thin in this row: only one external article and no direct positive or negative dated events. The phase-2 rationale mentions a CAD$40M+ Royal Canadian Air Force contract, but that contract evidence is not directly surfaced in the available evidence fields for this output row, so it should not be elevated beyond the membership rationale.

97
Obruta Space Solutions
lowweak
Opp 4
Risk 4

Thesis: Obruta operates in a strategically attractive area: autonomous docking for on-orbit servicing and logistics, with stated use cases including inspection, orbital refueling, satellite life extension, debris removal, and orbital logistics. That gives a plausible long-horizon opportunity narrative if product or customer validation emerges.

Why now: The only dated visible evidence is a company-site page with a May 20, 2026 describing the technology and target markets, which is relevant for strategic positioning but not enough to prove commercial inflection within the next year.

Evidence
  • May 20, 2026: Obruta describes 'safe, reliable, and autonomous spacecraft docking for on-orbit servicing and logistics' and lists applications such as orbital refueling, satellite life extension, debris removal, and orbital logistics. obruta.com

Caveats: Evidence is company-site descriptive context only. No third-party validation, financing, contract, or deployment evidence is shown.

98
Observable Space
lowweak
Opp 4
Risk 4

Thesis: Moderate opportunity based on the reviewed sources membership rationale that Observable Space was listed among notable space startup funding deals at $90 million. A funding round of that size can support growth over a 1 year+ horizon if deployed effectively.

Why now: Why now is the funding mention tied to article ID: but the reviewed sources provide no, operating specifics, or additional corroborating evidence.

Caveats: Funding alone is positive evidence but does not prove business quality. Article ID: is referenced without.

99
OMSPACE
lowweak
Opp 4
Risk 4

Thesis: The reviewed sources membership rationale says OMSPACE successfully launched a sounding rocket and plans an orbital launch vehicle by 2027 for small satellites. That suggests a real technical progression path if the company can convert suborbital progress into orbital capability over the next year-plus.

Why now: The reviewed sources' rationale references article: for a successful sounding-rocket launch and a 2027 orbital-launch target, but the underlying article summary/ is not included here, limiting recency and sequence assessment.

Caveats: Evidence is limited to a broad membership rationale without article detail. A sounding-rocket success is meaningfully earlier-stage than an orbital launch business. Risk and opportunity are both elevated relative to peers because the technology path is ambitious but still lightly evidenced.

100
Orbital
lowweak
Opp 4
Risk 3

Thesis: Orbital has modest evidence-backed opportunity because a dated within the recent evidence window article says it raised $5 million to fund an in-orbit computing demonstration next year and support initial work on its first purpose-built orbital compute satellite, Orbital-1, slated for 2028, indicating financing plus roadmap progress relevant to a 1 year+ horizon, June 10, 2026).

Why now: The recency is relatively fresh: the is based on June 10, 2026, inside the 90-day recent evidence window, and it frames both new capital and a next-year demo as near-to-medium-term strategic milestones.

Evidence
  • June 10, 2026: Orbital 'has raised $5 million to fund an in-orbit computing demonstration next year' and the pre-seed funds 'will also support initial work on its first purpose-built orbital compute satellite, Orbital-1, slated for 2028.' spacenews.com
  • Same dated article describes plans to deploy 'more than 100,000 orbital data centers' while funding disclosed is only a $5 million pre-seed raise, implying large execution and capital-intensity risk from article context. spacenews.com

Caveats: All retained evidence is weak context supporting article context; there is no direct positive event/fact available. Same-article repeated rows are not independent confirmation. The opportunity case depends on an early-stage roadmap and financing announcement; commercial traction is not directly evidenced in retained rows.

Risk view

Showing rows 301-320 of 438; 20 rows per page.

Sorted by raw risk score
RankCompanyScoreThesis / Evidence
301
Hensoldt AG
lowweak
Opp 1
Risk 1

Thesis: There is no direct negative evidence in the reviewed sources after recent evidence window, so a material risk thesis is unsupported.

Why now: No near-term or durable catalyst is established from the available evidence. Coverage debug shows 69 article IDs considered but 0 after recent evidence window and 0 evidence after dedupe.

Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Only context-level market-list mention is described, not a direct event or fact.

302
HEO USA
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is available. The main risk is that the available evidence is too indirect to establish HEO USA's own operating momentum or strategic durability.

Why now: Why now is weak because the cited technical-performance context is indirect, and the reviewed sources explicitly warns that relations are context-only and should not be used as counterparty propagation evidence.

Caveats: No current evidence is provided for: and Counterparty/component context is not strong direct evidence for HEO USA itself. Zero evidence available after recent evidence window.

303
Hermeus Corporation
lowweak
Opp 1
Risk 1

Thesis: No direct adverse evidence is available, leaving no support for a material risk thesis other than evidence scarcity.

Why now: There is no current timing signal from the reviewed sources. Coverage debug shows 29 article IDs considered but 0 after recent evidence window and 0 evidence available.

Caveats: Membership rationale references article ID, but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. The only described mention is indirect article context.

304
Hula Earth
lowweak
Opp 3
Risk 1

Thesis: No material adverse evidence is shown. Main risk is execution and classification ambiguity rather than documented negative business events.

Why now: The only dated retained context is a Startup Intros profile with April 16, 2026, stating Hula Earth uses IoT sensors and satellite imagery and had raised €1.6 million in seed funding; that is recent enough for a 1 year+ watchlist but too weak for a high-conviction thesis.

Evidence
  • Hula Earth develops an automated platform utilizing IoT BioT sensors and satellite imagery to monitor biodiversity in real time and 'raised €1.6 million in seed funding in November 2024'; April 16, 2026. startupintros.com

Caveats: Evidence is weak context and supporting article context, not direct company event/facts. The funding itself is described as having occurred in November 2024 inside an April 16, 2026 profile, so exact recency of the financing event is older than the profile date. Reviewed evidence itself says Earth observation fit is plausible but not strong from these reviewed sources alone.

305
Impulso
lowweak
Opp 1
Risk 1

Thesis: No direct adverse evidence is available. The only risk is uncertainty from insufficient company-specific information.

Why now: No timing catalyst is supported by the reviewed sources. Coverage debug shows 1 article considered but 0 after recent evidence window and 0 evidence available.

Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Counterparty context cannot be propagated into a direct thesis.

306
Infinite Orbits
lowweak
Opp 1
Risk 1

Thesis: Main risk is evidentiary: there is insufficient recent company-specific evidence in the reviewed sources to validate business progress, customer traction, or execution status.

Why now: There is no qualifying 90-day retained evidence. The only cited article mentioning Infinite Orbits is dated September 16, 2025, outside the reviewed sources' 90-day recent evidence window, so recency for any business progress is not established.

Caveats: Reviewed evidence shows zero evidence retained after recent evidence window. Do not use the older TechCrunch article as current recency proof. Absence of recent negative evidence is not positive evidence.

307
Innoseis
lowweak
Opp 2
Risk 1

Thesis: No material adverse evidence is provided. The main risk is evidentiary: the reviewed sources does not clearly establish business category fit, operating traction, or near-term durability.

Why now: Potentially relevant because the article context references funding and lunar-measurement selection, but the reviewed sources provide no dated evidence or, so recency and sequence cannot be verified beyond the membership rationale tied to

Caveats: No current evidence is provided for cited Zero evidence available after recent evidence window despite the membership rationale. Funding and technology-selection references are article-context level only here.

308
Integrate
lowweak
Opp 1
Risk 1

Thesis: No current material adverse thesis is supportable within the reviewed sources' retained recent evidence window evidence.

Why now: Why now is weak because the only specific company article summary in the reviewed sources were dated February 23, 2026 and was dropped by the 90-day recent evidence window, so it cannot support current ranking despite mentioning financing and a Space Force contract, February 23, 2026).

Caveats: The reviewed sources contain a representative article summary for stating Integrate 'closed a $17M Series A and landed a $25M space force contract to deploy secure program management software,' but the evidence recent evidence review says those rows were dropped as older than the March 29, 2026 cutoff, so they are not usable for current scoring. The company may be space-adjacent software rather than a direct space operator, per the reviewed sources' own membership rationale.

309
Integrated Launch Solutions, Inc.
lowweak
Opp 1
Risk 1

Thesis: No material negative thesis can be supported from retained evidence because the reviewed sources contain no direct negative rows within the recent evidence window.

Why now: No current catalyst is evidenced in retained rows.

Caveats: Phase-2 rationale says ILS provides engineering, mission design, range integration, and support for the STARLAUNCH pathway and cites: and: but neither summary nor is available here for citation. Coverage debug shows 7 articles considered and 0 after recent evidence window. Service-provider context alone is not directional proof without retained positive or negative evidence.

310
Integrity ISR
lowweak
Opp 1
Risk 1

Thesis: No material risk thesis can be supported because there is no retained direct negative evidence within the reviewed sources' recent evidence window.

Why now: No current business change or catalyst is evidenced in the retained rows.

Caveats: Phase-2 rationale references: about analysis of satellite maneuvers near an ICEYE satellite, but no or article summary is provided here for citation. Coverage debug shows 1 article considered and 0 after recent evidence window. Single-article descriptive context in phase-2 rationale is weaker than direct event/fact evidence and is uncitable here due to missing.

311
Intelsat
lowweak
Opp 2
Risk 1

Thesis: There is no material direct negative evidence in the reviewed sources. Main risk is evidence insufficiency rather than a documented adverse business development.

Why now: Why now is weak because coverage data shows 0 article IDs after recent evidence window and 0 evidence available after recent evidence window, so timing and durability cannot be validated from these reviewed sources.

Caveats: Membership rationale cites article IDs: and: but the reviewed sources provide no or summaries for them. Evidence recent evidence review shows kept_rows 0 and undated_rows_kept 0, so there is no usable direct evidence inside the ranking window. Cannot treat cohort membership as thesis attractiveness.

312
iQPS
lowweak
Opp 2
Risk 1

Thesis: No direct adverse evidence is present; the key risk is lack of retained post-recent evidence window evidence confirming launch cadence, financing, or customer demand.

Why now: Why now is limited because the support is only referenced through membership rationale citing articles and, but the reviewed sources provide no or retained evidence after recent evidence window.

Caveats: No or article summaries are provided for cited support articles and. Coverage data shows zero retained evidence after recent evidence window. Potentially interesting launch-agreement signal cannot be scored highly without direct reviewed sources evidence.

313
Island Green Capital
lowweak
Opp 0
Risk 1

Thesis: No direct adverse event is available, but evidence insufficiency and unresolved identity make it unsuitable for a directional opportunity call.

Why now: No timing-based catalyst is supported because no post-recent evidence window evidence were available.

Caveats: Phase2 rationale references article IDs: and: but no were provided in the reviewed sources. Reviewed evidence states summaries were about Molten Ventures and Isar Aerospace rather than clearly about Island Green Capital. Context-only mentions cannot support propagation.

314
Israel Aerospace Industries
lowweak
Opp 1
Risk 1

Thesis: No admissible direct negative evidence was available inside the 90-day recent evidence window, so there is no supportable adverse thesis from these reviewed sources alone.

Why now: There is no usable current evidence in the reviewed sources for this company: evidence recent evidence review no current evidence was retained and coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale references article: but no company-specific evidence are available for ranking use. unavailable in reviewed sources.

Caveats: Reviewed evidence provides no post-recent evidence window evidence. Membership rationale is not directional proof. Referenced: has no in the reviewed sources.

315
Karman Holdings Inc.
lowweak
Opp 2
Risk 1

Thesis: No direct negative evidence is available. The primary risk is that the available context is too generic to prove durable space-specific positioning or a differentiated 1 year+ thesis.

Why now: Why now is weak because there are no retained evidence after the 90-day cutoff date of March 29, 2026, despite multiple older considered articles.

Caveats: No current evidence is provided for and. Revenue facts are referenced only in the membership rationale, not available as direct evidence. Broad supply-chain context is weaker than company-specific contract or product evidence.

316
Kepler Communications
lowweak
Opp 1
Risk 1

Thesis: No material negative evidence is available. The low risk score reflects missing evidence rather than a proven absence of business risk.

Why now: There is no scoreable current catalyst because the reviewed sources contain no reviewed evidence after the 90-day recent evidence filter for this company.

Caveats: Membership rationale cites, and, but the supporting article details are not available here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. No current dated evidence means recency is uncertain.

317
Kessler Dynamics
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is available in the reviewed sources after recent evidence filtering, but absence of evidence is not evidence of low risk; practical ranking risk is mostly informational opacity.

Why now: There is no usable dated catalyst evidence in the reviewed sources for the 1 year+ horizon. The reviewed sources show 0 reviewed evidence after the 90-day cutoff and no representative article summary or for direct citation.

Caveats: Coverage is effectively empty after recent evidence filtering: evidence recent evidence review shows kept_rows 0 and coverage data shows evidence after recent evidence window 0. The reviewed sources references support references including: but no or quote/summary is provided, so it cannot support factual claims under the citation rule.

318
KinetX
lowweak
Opp 1
Risk 1

Thesis: No direct negative evidence is available, so there is no supportable risk thesis from these reviewed sources alone.

Why now: The only described context is that Intuitive Machines 'closed KinetX transaction' in article, but no business description, no, and no evidence are available after recent evidence filtering.

Caveats: Acquisition context alone is not directional proof for KinetX. No company-specific operating facts are available. Referenced has no in the reviewed sources.

319
Kratos Defense & Security Solutions Inc.
lowweak
Opp 1
Risk 1

Thesis: No material adverse evidence is retained in the reviewed sources within the recent evidence window, so there is no grounded negative thesis beyond general uncertainty from lack of current evidence.

Why now: Why now is weak because no article summaries or direct evidence were retained after the March 29, 2026 cutoff; recency is therefore insufficiently supported in these reviewed sources.

Caveats: Membership rationale references support references and, but no article or retained evidence are provided, so they cannot be cited as factual support under the output rules. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0.

320
Kurs Orbital
lowweak
Opp 2
Risk 1

Thesis: Current reviewed sources evidence does not show material adverse developments; the main risk is evidentiary uncertainty rather than a documented company setback.

Why now: The only retained evidence is an undated external sector index listing Kurs Orbital as operating in in-orbit servicing, so timing and recency are uncertain.

Evidence
  • Space Index lists Kurs Orbital, HQ Turin, Italy, status 'operating' within 'In-Orbit Servicing & Assembly Companies.' This is undated supporting article context, not a dated company-specific event. spaceindex.io

Caveats: Evidence is undated and the reviewed sources explicitly says undated external evidence is relevance context, not recency proof. Same-article repeated rows are not independent confirmation. No financing, contract, revenue, product milestone, or regulatory evidence is provided.